You are here

MYOMA UTERİ OLGULARINDA PLAZMA CA 125 DEĞERLERİ

Plasma CA125 Levels In Myoma Uteri

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Objective: Plasma CA 125 levels were measured in 40 women operated for myoma uteri. Material and methods: Study group was divided into two groups according to the mass of myoma uteri being larger (First group) or smaller (second group) than 14 weeks of gestation. Control group consisted of 20 women with normal pelvic ultrasonography and no pelvic complaint. ± ± ± first group, second group and the control group, respectively. There were no significant statistical difference between both myoma uteri groups and between the myoma uteri groups and control group (P>0. 05). Conclusion: Although there were high CA125 levels (>35 U/ml) in two patients in the first group (10%), CA 125 has no diagnostic value in myoma uteri.
Abstract (Original Language): 
Amaç: Myoma uteri tanısı ile öpere olan 40 hastada CA125 düzeyleri araştırıldı. Materyal ve metot: Çalışma grubu gebelik cesameti baz alınarak 14 haftadan büyük (Grup 1) ve 14 haftadan küçükfGrup 2) cesameti olan yirmişer kişilik iki gruba ayrıldı. Hiçbir jinekolojik şikayeti olmayan ve normal pelvik ultrasonografileri olan 20 hastadan kontrol grubu oluşturuldu. Bulgular: Ortalama plazma CA 125 düzeyleri büyük myomlarda 13.49±12.41 SD, küçük myomlarda 7.8±5.46 SD, kontrol grubunda 7.67±2.51 SD olup her iki my o m grubu arasında ve myom grupları ile kontrol grubu arasında istatistik/' anlamlılık gösteren fark bulunamadı. (P>0.05) Sonuç: Her ne kadar büyük myomlarda 35 U/ml'nin üzerinde CA 125 değer-lerine rastlansada (çalışmamızda 2 olgu %10) myoma uteri olguların-da CA 125 düzeyinin tanısal önemi olmadığı sonucuna varılmıştır.
8-10

REFERENCES

References: 

1. Vasiliev SA, Schaerth J, Campeau J. Serum Ca125 levels in preoperative evaluation of pelvic masses. Obstet Gynecol 1988; 71: 751.
2. Dawood YM, Dawood FSK. Plasma insulin like growth fackor I, Ca125, estrogen and progesterone in women with liyomyomas. Fertility Sterility 1994; 61: 617.
3. Takahashi K, Hagata H, Kjima S. Clinical usefulness of determination of Ca125 levels in the serum and menstruel blood. Gynecol Obstet Invest 1988; 26: 63.
4. Einhorn N, Bast RC, Knapp RC. Preoperative evaluation of serum Ca125 levels in patients with primary epithelial ovrian cancer. Obstet Gynecol 1980; 67: 414.
5. Niloff JM, Klug IL, Schaetzel E. Evaluation of serum Ca125 in carcinoma of the fallopian tube endometrium and endocervix. Am J Obstet Gynecol 1984; 48: 1057.
6. Alagöz T, Buller R, Bermon M. What is a normal Ca125 level. Gynecol Oncol 1994; 53: 93.
7. Fujii S, Kanishi L, Nanbu Y. analysis of the level of Ca125, CEA and Ca19-9 in the dedection of cervical adenocarcinoma. Cancer 1988; 63: 541.
8. Malkasian GD, Padratz RC, Stanhope CR. Ca125 in gynecologic practice. Am J Obstet Gynecol 1986; 155:
515.
9. Pittaway DE, Fatez JA. Serum Ca125 levels increase during menses. Am. J Obstet Gynecol 1987; 156: 75.

Thank you for copying data from http://www.arastirmax.com